Protalix BioTherapeutics (PLX) EBT Margin (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) EBT Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Protalix BioTherapeutics | 194.29 Mn | 153.63 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,821.00 |
| Mar 31, 2026 | 10,372.00 |
| Dec 31, 2025 | -5,362.00 |
| Sep 30, 2025 | 832.00 |
| Jun 30, 2025 | 4,112.00 |
| Mar 31, 2025 | -10,203.00 |
| Dec 31, 2024 | 4,372.00 |
| Sep 30, 2024 | 3,826.00 |
| Jun 30, 2024 | 10,942.00 |
| Mar 31, 2024 | 8,403.00 |
| Dec 31, 2023 | -19,369.00 |
| Sep 30, 2023 | -7,263.00 |
| Jun 30, 2023 | 8,664.00 |
| Mar 31, 2023 | 663.00 |
| Dec 31, 2022 | -1,210.00 |
| Sep 30, 2022 | 3,579.00 |
| Jun 30, 2022 | -4,673.00 |
| Mar 31, 2022 | 6,315.00 |
| Dec 31, 2021 | -4,173.00 |
| Sep 30, 2021 | 14,126.00 |